About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
2020 SOHO Update on Relapsed FL: Salvage Bendamustine in Rituximab Refractory Pts, PI3K Inhibitors, Lenalidomide + Rituximab, EZH2i Tazemetostat, Autologous SCT
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Nathan H. Fowler
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Nathan H. Fowler
87 views
December 15, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
Lymphoma
09:26
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on MZL: Epidemiology and Outcomes in a Mexican Cent…
Feat.
R. Córdova
25:00
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on MZL: Genetic Subtype Specific Entities, Antibiot…
Feat.
E. Zucca
14:51
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Relapsed FL: Salvage Bendamustine in Rituximab R…
Feat.
N. Fowler
08:38
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO MAVORIC Update on R/R CTCL: What Is the Impact of Concomit…
Feat.
L. Geskin
15:22
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on R/R PTCL: Is There a Single Paradigm Overall? Ca…
Feat.
S. Horwitz
13:26
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Newly Diagnosed PTCL: Should All Pts Undergo Upf…
Feat.
K. Savage
08:07
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on 1L Advanced cHL: What Are the Outcomes in HIV-cH…
Feat.
J. José Del Moral
21:36
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Be…
Feat.
D. Straus
22:32
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on IO for T-ALL/T-NHL: Is UCART7 Effective at Kill…
Feat.
J. DiPersio
15:55
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
R/R HL Updates: What Are Frontline Therapeutic Choices and How Can W…
Feat.
A. Herrera
07:11
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on PB-DLBCL: Does the Role of RT Differ Between Sta…
Feat.
S. Ma
18:48
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell…
Feat.
R. Brentjens
09:59
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on R/R cHL: Can We Improve Chemo With ADCs and CPI…
Feat.
D. Straus
11:13
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Dise…
Feat.
S. Giralt
10:17
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on DLBCL: Can Genomics Improve Patient Clinical Out…
Feat.
S. Dave
10:21
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Follicular Lymphoma: Is Watch and Wait Still App…
Feat.
R. Marcus
09:54
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Next Steps in T-Cell Lymphoma: Is Personalized Therapy Pos…
Feat.
K. Savage
09:51
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Next Steps in MCL: Is ASCT Appropriate for All Patients? A…
Feat.
J. Cohen
21:24
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Genomics in DLBCL: How Does Gene Expression …
Feat.
S. Dave
12:34
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on DLBCL: Can We Use CRISPR and Drug Screening to …
Feat.
S. Dave
15:26
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on DLBCL: Can We Go Beyond R-CHOP by Incorporating…
Feat.
S. Dave
15:25
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on CAR-T in Aggressive B-NHL: Are There Differe…
Feat.
P. Riedell
13:41
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on Frontline MCL: How Do Guidelines Differ Between…
Feat.
S. Le Gouill
14:41
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on R/R MCL: What Are the Long Term Outcomes Wit…
Feat.
J. Cohen
15:00
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on R/R DLBCL: Is There Still a Role for AutoHCT? I…
Feat.
S. Smith
18:06
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on IO in Aggressive B-nHL: What Is the ORR With Mo…
Feat.
M. Hutchings
17:13
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Waldenstrom Macroglobulinemia: What Are the Effe…
Feat.
M. Gertz
06:16
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Frontline MCL: How Effective Is Ibrutinib+Veneto…
Feat.
M. Wang
